Healios K.K.
HLOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $560 | $121 | $90 | $41 |
| % Growth | 362.8% | 34.4% | 119.5% | – |
| Cost of Goods Sold | $128 | $13 | $0 | $0 |
| Gross Profit | $432 | $108 | $90 | $41 |
| % Margin | 77.1% | 89.3% | 100% | 100% |
| R&D Expenses | $1,960 | $2,304 | $3,808 | $3,700 |
| G&A Expenses | $1,374 | $1,184 | $1,449 | $1,722 |
| SG&A Expenses | $1,374 | $1,184 | $1,449 | $1,722 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$59 | -$1 | $12 | $3 |
| Operating Expenses | $3,275 | $3,487 | $5,269 | $5,425 |
| Operating Income | -$2,843 | -$3,379 | -$5,179 | -$5,384 |
| % Margin | -507.7% | -2,792.6% | -5,754.4% | -13,131.7% |
| Other Income/Exp. Net | -$1,218 | -$247 | -$151 | $923 |
| Pre-Tax Income | -$4,061 | -$3,626 | -$5,330 | -$4,462 |
| Tax Expense | $166 | $187 | -$160 | $450 |
| Net Income | -$4,235 | -$3,823 | -$5,170 | -$4,912 |
| % Margin | -756.3% | -3,159.5% | -5,744.4% | -11,980.5% |
| EPS | -47.87 | -56.22 | -90.69 | -93.4 |
| % Growth | 14.9% | 38% | 2.9% | – |
| EPS Diluted | -47.87 | -56.22 | -90.69 | -93.4 |
| Weighted Avg Shares Out | 88 | 68 | 57 | 53 |
| Weighted Avg Shares Out Dil | 88 | 68 | 57 | 53 |
| Supplemental Information | – | – | – | – |
| Interest Income | $373 | $456 | $346 | $1,728 |
| Interest Expense | $1,589 | $704 | $500 | $802 |
| Depreciation & Amortization | $297 | $224 | $386 | $262 |
| EBITDA | -$2,175 | -$2,698 | -$4,771 | -$5,117 |
| % Margin | -388.4% | -2,229.8% | -5,301.1% | -12,480.5% |